Chen Yixin, Zhang Ting, Qin Baoding, Zhang Rui, Liu Minting, Guo Ruomi, Zhu Yanhua, Zeng Jie, Chen Yanming
Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology & Guangzhou Municipal Key Laboratory of Mechanistic and Translational Obesity Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Department of Medical Ultrasound, Guangdong Provincial Key Laboratory of Diabetology & Guangzhou Municipal Key Laboratory of Mechanistic and Translational Obesity Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Abdom Radiol (NY). 2025 Mar;50(3):1457-1466. doi: 10.1007/s00261-024-04591-3. Epub 2024 Sep 21.
Ectopic fat deposition, involving lipid infiltration within organs and fat accumulating surrounding organs, plays a crucial role in the development of metabolic abnormalities in obesity. Current imaging measurements of obesity primarily focus on lipid infiltration within liver, neglecting fat deposition in other areas. This study aims to explore the methods of measuring and correlating different types of abdominal ectopic fat deposition in obese patients using magnetic resonance imaging (MRI) and ultrasound techniques, and to investigate the relationship between these fat parameters and obesity-related metabolic markers.
Abdominal ectopic fat deposition including liver fat content, mesenteric fat thickness (MFT), perirenal fat thickness (PrFT) and preperitoneal fat thickness (PFT) were measured in 220 overweight/obese patients using both MRI and ultrasound techniques. Correlation analysis validated the concordance of fat parameters at specific sites between the two imaging methods and identified the cutoff values of hepatic attenuation coefficient (AC) for diagnosis of liver steatosis. Additionally, we investigated the correlation between fat parameters by both methods and obesity-related metabolic markers.
Ultrasonic measurement of PrFT and hepatic AC both had high correlation with PrFT (r = 0.829, p < 0.001) and hepatic Proton-density fat fraction (PDFF, r = 0.822, p < 0.001) measured via MR. Hepatic AC cutoff values for diagnosing mild, moderate, and severe fatty liver were 0.705 dB/cm/MHz (AUC = 0.922), 0.755 dB/cm/MHz (AUC = 0.923), and 0.875 dB/cm/MHz (AUC = 0.890) respectively. Hepatic AC correlated significantly with AST and ALT (r = 0.477 ~ 0.533, p < 0.001). MFT measured by ultrasound were positively associated with glycated hemoglobin (r = 0.324 ~ 0.371, p < 0.001) and serum triglyceride levels (r = 0.303 ~ 0.353, p < 0.001). PrFT measured by both methods showed significant positive correlations with serum creatinine levels (r = 0.305 ~ 0.308, p < 0.001).
Both MRI and ultrasound demonstrate metabolic correlations in quantifying mesenteric, hepatic, and perirenal fat. In addition to assessment of liver fat content, the measurements of ectopic fat deposition by MRI or ultrasound are a simple and crucial way for comprehensive fat evaluation in individuals with overweight/obesity.
异位脂肪沉积,包括器官内脂质浸润和器官周围脂肪堆积,在肥胖相关代谢异常的发生发展中起关键作用。目前肥胖的影像学测量主要集中在肝脏内的脂质浸润,而忽略了其他部位的脂肪沉积。本研究旨在探讨利用磁共振成像(MRI)和超声技术测量肥胖患者不同类型腹部异位脂肪沉积并进行相关性分析的方法,并研究这些脂肪参数与肥胖相关代谢标志物之间的关系。
采用MRI和超声技术对220例超重/肥胖患者测量腹部异位脂肪沉积,包括肝脏脂肪含量、肠系膜脂肪厚度(MFT)、肾周脂肪厚度(PrFT)和腹膜前脂肪厚度(PFT)。相关性分析验证了两种成像方法在特定部位脂肪参数的一致性,并确定了诊断肝脂肪变性的肝脏衰减系数(AC)临界值。此外,我们还研究了两种方法测量的脂肪参数与肥胖相关代谢标志物之间的相关性。
超声测量的PrFT和肝脏AC与MRI测量的PrFT(r = 0.829,p < 0.001)和肝脏质子密度脂肪分数(PDFF,r = 0.822,p < 0.001)均具有高度相关性。诊断轻度、中度和重度脂肪肝的肝脏AC临界值分别为0.705 dB/cm/MHz(AUC = 0.922)、0.755 dB/cm/MHz(AUC = 0.923)和0.875 dB/cm/MHz(AUC = 0.890)。肝脏AC与AST和ALT显著相关(r = 0.477 ~ 0.533,p < 0.001)。超声测量的MFT与糖化血红蛋白(r = 0.324 ~ 0.371,p < 0.001)和血清甘油三酯水平(r = 0.303 ~ 0.353,p < 0.001)呈正相关。两种方法测量的PrFT与血清肌酐水平均呈显著正相关(r = 0.305 ~ 0.308,p < 0.001)。
MRI和超声在量化肠系膜、肝脏和肾周脂肪方面均显示出代谢相关性。除了评估肝脏脂肪含量外,通过MRI或超声测量异位脂肪沉积是超重/肥胖个体进行全面脂肪评估的一种简单而关键的方法。